206
Karyopharm Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
152
FY23:
141
FY24:
139
FY25:
140
(positive)
Change from FY21 to FY25
millions USD
FY21:
−102
FY22:
−147
FY23:
−134
FY24:
−125
FY25:
−96.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−97.0
FY22:
−139
FY23:
−118
FY24:
−83.3
FY25:
−87.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−124
FY22:
−165
FY23:
−143
FY24:
−76.4
FY25:
−196
(positive)
Change from FY21 to FY25
millions USD
FY21:
−124
FY22:
−165
FY23:
−143
FY24:
−76.4
FY25:
−196
All amounts in millions USD